CP119781421 | N.S. to start administering AstraZeneca vaccines

CP120960271 | Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64

CP122404571 | Quebec reports first blood clot death in woman who received AstraZeneca vaccine

CP122830710 | New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine

CP120133819 | N.S. to vaccinate at homeless shelters using mobile van clinics

CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma

CP124342421 | Manitoba approves different second dose after AstraZeneca COVID-19 vaccine

CP121635062 | AstraZeneca vaccine to remain authorized in Canada

CP124397371 | AstraZeneca recipients can get Moderna or Pfizer for second dose: NACI

CP123251321 | Ontario to get more than 250,000 AstraZeneca doses

Placeline/People

City Vaughan

Country Canada

N.S. pauses use of AstraZeneca vaccine

Nova Scotia has become the latest province to pause the rollout of the Oxford-AstraZeneca vaccine over concerns of a rare blood clotting side effect that has potentially been linked to the vaccine. Premier Iain Rankin said over 1,000 appointments for AstraZeneca have been cancelled in the province and residents have voiced a preference for either the Pfizer-BioNTech or the Moderna vaccines.

Source name:

Unique identifier: CP123262421

Legacy Identifier: n_COVID-NS20210512T1730

Type: Video

Duration: 2m25s

Dimensions: 1920px × 1080px 134.20 MB

Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.

Create Date: 5/12/2021 5:30:00 PM

Display aspect ratio: 16:9